Prospective, single arm, post-marketing clinical study of EYECRYLâ?¢ PLUS (600) intraocular lens to assess performance and safety in patients undergoing cataract surgery.

one0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年3月6日

试验速览

暂无简介。

•1. Age 18 year or greater
•2. Cataract
•3. Calculated IOL power is within the range of the study IOLs.
•4. Given consent to use device related data for scientific purpose
•5. Clear intraocular media other than cataract
•6. Patient willing to participate and sign informed consent
•7. Patient willing to come for all post-operative follow-up
•8. Female participants of child bearing potential and male participants whose partner
•is of child bearing potential must be willing to ensure that they or their partner use
•effective contraception during the study

•1. Previous intraocular or corneal surgery
•2. Traumatic cataract
•3. Pregnancy
•4. Concurrent participation or participation in the last 30 days in any other clinical
•5. Irregular astigmatism
•6. Instability of keratometry or biometry measurements
•7. Vulnerable subject.
•8. Patients receiving chloroquine treatment.
•9. Patient having Microphthalmia.
•10. Patient having Chronic Uveitis.
•11. Patient suffering from corneal dystrophy or endothelial insufficiency.
•12. Patient having active ocular diseases (active diabetic retinopathy, uncontrolled

发起方